Literature DB >> 7678469

Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule.

H Zaghouani1, R Steinman, R Nonacs, H Shah, W Gerhard, C Bona.   

Abstract

Synthetic peptides corresponding to microbial epitopes stimulate T cell immunity but their immunogenicity is poor and their half-lives are short. A viral epitope inserted into the complementarity-determining region 3 (CDR3) loop of the heavy chain of a self immunoglobulin (Ig) molecule was generated from the Ig context and was presented by I-Ed class II molecules to virus-specific, CD4+ T cells. Chimeric Ig-peptide was presented 100 to 1000 times more efficiently than free synthetic peptide and was able to prime virus-specific T cells in vivo. These features suggest that antigenized Ig can provide an improved and safe vaccine for the presentation of microbial and other peptides.

Mesh:

Substances:

Year:  1993        PMID: 7678469     DOI: 10.1126/science.7678469

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  38 in total

1.  The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.

Authors:  I B Rasmussen; E Lunde; T E Michaelsen; B Bogen; I Sandlie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination.

Authors:  Lilin Wang; Dan Smith; Simona Bot; Luis Dellamary; Amy Bloom; Adrian Bot
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Immunoglobulin class switching appears to be regulated by B-cell antigen receptor-specific T-cell action.

Authors:  Hans Lange; Oliver Hecht; Michael Zemlin; Ahmad Trad; Radu I Tanasa; Harry W Schroeder; Hilmar Lemke
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

4.  Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Authors:  K Manoutcharian; L I Terrazas; G Gevorkian; G Acero; P Petrossian; M Rodriguez; T Govezensky
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site.

Authors:  C F Barbas; L R Languino; J W Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

7.  F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes.

Authors:  C Liu; J Goldstein; R F Graziano; J He; J K O'Shea; Y Deo; P M Guyre
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

8.  Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus.

Authors:  T D Brumeanu; S Casares; A Bot; S Bot; C A Bona
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Scorpion toxins as natural scaffolds for protein engineering.

Authors:  C Vita; C Roumestand; F Toma; A Ménez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Epitope-specific tolerance induction with an engineered immunoglobulin.

Authors:  E T Zambidis; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.